Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects
•Structural and functional retinal changes are present in Parkinson's disease (PD).•Phosphorylated α-synuclein (psyn) is a specific biomarker of PD.•Psyn-immunoreactive nerve fibers were present in the retina in 7/9 subjects with PD.•Psyn-immunoreactive neuronal perikarya were present in 1 PD s...
Saved in:
Published in | Neuroscience letters Vol. 571; pp. 34 - 38 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier Ireland Ltd
13.06.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Structural and functional retinal changes are present in Parkinson's disease (PD).•Phosphorylated α-synuclein (psyn) is a specific biomarker of PD.•Psyn-immunoreactive nerve fibers were present in the retina in 7/9 subjects with PD.•Psyn-immunoreactive neuronal perikarya were present in 1 PD subject.•This pathology may contribute to structural and functional retinal changes in PD.
Visual symptoms are relatively common in Parkinson's disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of aggregated α-synuclein is thought to be a central pathogenic event in the PD brain but there have not as yet been reports of retinal synucleinopathy. Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD (N=9), dementia with Lewy bodies (DLB; N=3), Alzheimer's disease (N=3), progressive supranuclear palsy (N=2) as well as elderly normal control subjects (N=4). These were immunohistochemically stained with an antibody against α-synuclein phosphorylated at serine 129, which is a specific molecular marker of synucleinopathy. Phosphorylated α-synuclein-immunoreactive (p-syn IR) nerve fibers were present in 7/9 PD subjects and in 1/3 DLB subjects; these were sparsely distributed and superficially located near or at the inner retinal surface. The fibers were either long and straight or branching, often with multiple en-passant varicosities along their length. The straight fibers most often had an orientation that was radial with respect to the optic disk. Together, these features are suggestive of either retinopetal/centrifugal fibers or of ganglion cell axons. In one PD subject there were sparse p-syn IR neuronal cell bodies with dendritic morphology suggestive of G19 retinal ganglion cells or intrinsically photosensitive ganglion cells. There were no stained nerve fibers or other specific staining in any of the non-PD or non-DLB subjects. It is possible that at least some of the observed visual function impairments in PD subjects might be due to α-synucleinopathy. |
---|---|
AbstractList | Visual symptoms are relatively common in Parkinson's disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of aggregated alpha -synuclein is thought to be a central pathogenic event in the PD brain but there have not as yet been reports of retinal synucleinopathy. Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD (N = 9), dementia with Lewy bodies (DLB; N = 3), Alzheimer's disease (N = 3), progressive supranuclear palsy (N = 2) as well as elderly normal control subjects (N = 4). These were immunohistochemically stained with an antibody against alpha -synuclein phosphorylated at serine 129, which is a specific molecular marker of synucleinopathy. Phosphorylated alpha -synuclein-immunoreactive (p-syn IR) nerve fibers were present in 7/9 PD subjects and in 1/3 DLB subjects; these were sparsely distributed and superficially located near or at the inner retinal surface. The fibers were either long and straight or branching, often with multiple en-passant varicosities along their length. The straight fibers most often had an orientation that was radial with respect to the optic disk. Together, these features are suggestive of either retinopetal/centrifugal fibers or of ganglion cell axons. In one PD subject there were sparse p-syn IR neuronal cell bodies with dendritic morphology suggestive of G19 retinal ganglion cells or intrinsically photosensitive ganglion cells. There were no stained nerve fibers or other specific staining in any of the non-PD or non-DLB subjects. It is possible that at least some of the observed visual function impairments in PD subjects might be due to alpha -synucleinopathy. •Structural and functional retinal changes are present in Parkinson's disease (PD).•Phosphorylated α-synuclein (psyn) is a specific biomarker of PD.•Psyn-immunoreactive nerve fibers were present in the retina in 7/9 subjects with PD.•Psyn-immunoreactive neuronal perikarya were present in 1 PD subject.•This pathology may contribute to structural and functional retinal changes in PD. Visual symptoms are relatively common in Parkinson's disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of aggregated α-synuclein is thought to be a central pathogenic event in the PD brain but there have not as yet been reports of retinal synucleinopathy. Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD (N=9), dementia with Lewy bodies (DLB; N=3), Alzheimer's disease (N=3), progressive supranuclear palsy (N=2) as well as elderly normal control subjects (N=4). These were immunohistochemically stained with an antibody against α-synuclein phosphorylated at serine 129, which is a specific molecular marker of synucleinopathy. Phosphorylated α-synuclein-immunoreactive (p-syn IR) nerve fibers were present in 7/9 PD subjects and in 1/3 DLB subjects; these were sparsely distributed and superficially located near or at the inner retinal surface. The fibers were either long and straight or branching, often with multiple en-passant varicosities along their length. The straight fibers most often had an orientation that was radial with respect to the optic disk. Together, these features are suggestive of either retinopetal/centrifugal fibers or of ganglion cell axons. In one PD subject there were sparse p-syn IR neuronal cell bodies with dendritic morphology suggestive of G19 retinal ganglion cells or intrinsically photosensitive ganglion cells. There were no stained nerve fibers or other specific staining in any of the non-PD or non-DLB subjects. It is possible that at least some of the observed visual function impairments in PD subjects might be due to α-synucleinopathy. Visual symptoms are relatively common in Parkinson’s disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of aggregated α-synuclein is thought to be a central pathogenic event in the PD brain but there have not as yet been reports of retinal synucleinopathy. Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD ( N = 9), dementia with Lewy bodies (DLB; N = 3), Alzheimer’s disease ( N = 3), progressive supranuclear palsy ( N = 2) as well as elderly normal control subjects ( N = 4). These were immunohistochemically stained with an antibody against α-synuclein phosphorylated at serine 129, which is a specific molecular marker of synucleinopathy. Phosphorylated α-synuclein-immunoreactive (p-syn IR) nerve fibers were present in 7/9 PD subjects and in 1/3 DLB subjects; these were sparsely distributed and superficially located near or at the inner retinal surface. The fibers were either long and straight or branching, often with multiple en-passant varicosities along their length. The straight fibers most often had an orientation that was radial with respect to the optic disk. Together, these features are suggestive of either retinopetal/centrifugal fibers or of ganglion cell axons. In one PD subject there were sparse p-syn IR neuronal cell bodies with dendritic morphology suggestive of G19 retinal ganglion cells or intrinsically photosensitive ganglion cells. There were no stained nerve fibers or other specific staining in any of the non-PD or non-DLB subjects. It is possible that at least some of the observed visual function impairments in PD subjects might be due to α-synucleinopathy. Visual symptoms are relatively common in Parkinson's disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of aggregated α-synuclein is thought to be a central pathogenic event in the PD brain but there have not as yet been reports of retinal synucleinopathy. Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD (N=9), dementia with Lewy bodies (DLB; N=3), Alzheimer's disease (N=3), progressive supranuclear palsy (N=2) as well as elderly normal control subjects (N=4). These were immunohistochemically stained with an antibody against α-synuclein phosphorylated at serine 129, which is a specific molecular marker of synucleinopathy. Phosphorylated α-synuclein-immunoreactive (p-syn IR) nerve fibers were present in 7/9 PD subjects and in 1/3 DLB subjects; these were sparsely distributed and superficially located near or at the inner retinal surface. The fibers were either long and straight or branching, often with multiple en-passant varicosities along their length. The straight fibers most often had an orientation that was radial with respect to the optic disk. Together, these features are suggestive of either retinopetal/centrifugal fibers or of ganglion cell axons. In one PD subject there were sparse p-syn IR neuronal cell bodies with dendritic morphology suggestive of G19 retinal ganglion cells or intrinsically photosensitive ganglion cells. There were no stained nerve fibers or other specific staining in any of the non-PD or non-DLB subjects. It is possible that at least some of the observed visual function impairments in PD subjects might be due to α-synucleinopathy.Visual symptoms are relatively common in Parkinson's disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of aggregated α-synuclein is thought to be a central pathogenic event in the PD brain but there have not as yet been reports of retinal synucleinopathy. Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD (N=9), dementia with Lewy bodies (DLB; N=3), Alzheimer's disease (N=3), progressive supranuclear palsy (N=2) as well as elderly normal control subjects (N=4). These were immunohistochemically stained with an antibody against α-synuclein phosphorylated at serine 129, which is a specific molecular marker of synucleinopathy. Phosphorylated α-synuclein-immunoreactive (p-syn IR) nerve fibers were present in 7/9 PD subjects and in 1/3 DLB subjects; these were sparsely distributed and superficially located near or at the inner retinal surface. The fibers were either long and straight or branching, often with multiple en-passant varicosities along their length. The straight fibers most often had an orientation that was radial with respect to the optic disk. Together, these features are suggestive of either retinopetal/centrifugal fibers or of ganglion cell axons. In one PD subject there were sparse p-syn IR neuronal cell bodies with dendritic morphology suggestive of G19 retinal ganglion cells or intrinsically photosensitive ganglion cells. There were no stained nerve fibers or other specific staining in any of the non-PD or non-DLB subjects. It is possible that at least some of the observed visual function impairments in PD subjects might be due to α-synucleinopathy. Visual symptoms are relatively common in Parkinson's disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of aggregated α-synuclein is thought to be a central pathogenic event in the PD brain but there have not as yet been reports of retinal synucleinopathy. Retinal wholemounts were prepared from subjects with a primary clinicopathological diagnosis of PD (N=9), dementia with Lewy bodies (DLB; N=3), Alzheimer's disease (N=3), progressive supranuclear palsy (N=2) as well as elderly normal control subjects (N=4). These were immunohistochemically stained with an antibody against α-synuclein phosphorylated at serine 129, which is a specific molecular marker of synucleinopathy. Phosphorylated α-synuclein-immunoreactive (p-syn IR) nerve fibers were present in 7/9 PD subjects and in 1/3 DLB subjects; these were sparsely distributed and superficially located near or at the inner retinal surface. The fibers were either long and straight or branching, often with multiple en-passant varicosities along their length. The straight fibers most often had an orientation that was radial with respect to the optic disk. Together, these features are suggestive of either retinopetal/centrifugal fibers or of ganglion cell axons. In one PD subject there were sparse p-syn IR neuronal cell bodies with dendritic morphology suggestive of G19 retinal ganglion cells or intrinsically photosensitive ganglion cells. There were no stained nerve fibers or other specific staining in any of the non-PD or non-DLB subjects. It is possible that at least some of the observed visual function impairments in PD subjects might be due to α-synucleinopathy. |
Author | Shill, Holly A. Cuenca, Nicolás Carew, Jeremiah Sue, Lucia I. Akiyama, Haruhiko Beach, Thomas G. Serrano, Geidy Sabbagh, Marwan N. Adler, Charles H. |
AuthorAffiliation | d Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Spain b Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, United States c Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan a Banner Sun Health Research Institute, 10515W. Santa Fe Drive, Sun City, AZ 85351, United States |
AuthorAffiliation_xml | – name: c Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan – name: d Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Spain – name: a Banner Sun Health Research Institute, 10515W. Santa Fe Drive, Sun City, AZ 85351, United States – name: b Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, United States |
Author_xml | – sequence: 1 givenname: Thomas G. surname: Beach fullname: Beach, Thomas G. email: thomas.beach@bannerhealth.com organization: Banner Sun Health Research Institute, 10515W. Santa Fe Drive, Sun City, AZ 85351, United States – sequence: 2 givenname: Jeremiah surname: Carew fullname: Carew, Jeremiah organization: Banner Sun Health Research Institute, 10515W. Santa Fe Drive, Sun City, AZ 85351, United States – sequence: 3 givenname: Geidy surname: Serrano fullname: Serrano, Geidy organization: Banner Sun Health Research Institute, 10515W. Santa Fe Drive, Sun City, AZ 85351, United States – sequence: 4 givenname: Charles H. surname: Adler fullname: Adler, Charles H. organization: Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, United States – sequence: 5 givenname: Holly A. surname: Shill fullname: Shill, Holly A. organization: Banner Sun Health Research Institute, 10515W. Santa Fe Drive, Sun City, AZ 85351, United States – sequence: 6 givenname: Lucia I. surname: Sue fullname: Sue, Lucia I. organization: Banner Sun Health Research Institute, 10515W. Santa Fe Drive, Sun City, AZ 85351, United States – sequence: 7 givenname: Marwan N. surname: Sabbagh fullname: Sabbagh, Marwan N. organization: Banner Sun Health Research Institute, 10515W. Santa Fe Drive, Sun City, AZ 85351, United States – sequence: 8 givenname: Haruhiko surname: Akiyama fullname: Akiyama, Haruhiko organization: Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan – sequence: 9 givenname: Nicolás surname: Cuenca fullname: Cuenca, Nicolás organization: Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Spain |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24785101$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUd1qFDEYDVKx2-obiMyd3sz6JfOTGS8EKfUHCu2FXodM8o2bNZOsSWZhH6sv0mdqlt2KeqGFDxLIOSfnO-eMnDjvkJCXFJYUaPt2vXQ4W0xLBrReQh7Gn5AF7Tgrec_ZCVlABXVZ9TWckrMY1wDQ0KZ-Rk5ZzbsmqyyIvln5uFn5sLMyoS7ubsu4c7OyaFxppml2PqBUyWyxCJiMk7bI_wa_v6DFCV2KhXHFjQw_jIvevY6FNhFlxCLOwxpVis_J01HaiC-O5zn59vHy68Xn8ur605eLD1elqhtI5aCoRt4CA-QIvAGq2IhQ6WFQUDMObQOtkkr3HDsO2DLe5U1bTce82ThW5-T9QXczDxNqlb0FacUmmEmGnfDSiD9fnFmJ734r6qanvKFZ4M1RIPifM8YkJhMVWisd-jmKnF7V97xru0dAc_Btz6HJ0Fe_2_rl56GFDHh3AKjgYww4CmWSTMbvXRorKIh95WItDpWLfeUC8jCeyfVf5Af9_9COWWEuZGswiKgMOoXahNyZ0N78W-Aeg5LLZA |
CitedBy_id | crossref_primary_10_1212_WNL_0000000000004020 crossref_primary_10_1212_CPJ_0000000000000719 crossref_primary_10_1038_s41598_023_35229_x crossref_primary_10_1038_srep29523 crossref_primary_10_1109_TCDS_2024_3520976 crossref_primary_10_1016_j_jns_2019_06_009 crossref_primary_10_4103_mgmj_mgmj_296_24 crossref_primary_10_1167_iovs_17_23240 crossref_primary_10_1016_j_neuroscience_2024_11_073 crossref_primary_10_1038_s41531_023_00570_5 crossref_primary_10_1093_jnen_nly056 crossref_primary_10_3390_ijms20133164 crossref_primary_10_3389_fnagi_2017_00214 crossref_primary_10_1016_j_neucli_2021_02_003 crossref_primary_10_3233_JPD_191830 crossref_primary_10_1002_mds_26411 crossref_primary_10_1007_s00401_018_01956_z crossref_primary_10_3233_JPD_230293 crossref_primary_10_1212_WNL_0000000000006157 crossref_primary_10_1016_j_exer_2022_109351 crossref_primary_10_3390_biom13010180 crossref_primary_10_1002_mds_26887 crossref_primary_10_3233_JPD_140485 crossref_primary_10_30629_2658_7947_2021_26_6_29_34 crossref_primary_10_1007_s11055_023_01487_5 crossref_primary_10_1186_s40478_018_0596_z crossref_primary_10_3389_fnins_2021_726476 crossref_primary_10_3389_fneur_2017_00206 crossref_primary_10_1002_mds_27454 crossref_primary_10_2139_ssrn_3985417 crossref_primary_10_3390_neurolint15010012 crossref_primary_10_1016_j_neulet_2022_136789 crossref_primary_10_1080_10408363_2019_1711359 crossref_primary_10_1177_24741264231206607 crossref_primary_10_3389_fnins_2020_567129 crossref_primary_10_1038_s41598_018_26078_0 crossref_primary_10_1007_s00415_018_9051_0 crossref_primary_10_1016_j_bbr_2017_07_040 crossref_primary_10_1002_acn3_146 crossref_primary_10_1016_j_brainres_2023_148603 crossref_primary_10_1167_iovs_61_6_12 crossref_primary_10_1021_acschemneuro_8b00383 crossref_primary_10_1097_MD_0000000000035354 crossref_primary_10_31083_j_jin2301023 crossref_primary_10_1007_s00415_016_8230_0 crossref_primary_10_3233_JAD_231123 crossref_primary_10_1007_s00702_015_1405_5 crossref_primary_10_1007_s13760_020_01274_w crossref_primary_10_1186_s40478_023_01575_0 crossref_primary_10_1016_j_jocn_2019_05_033 crossref_primary_10_3389_fnins_2021_799526 crossref_primary_10_1002_alz_13529 crossref_primary_10_17116_jnevro20221221125 crossref_primary_10_1016_j_ajpath_2016_05_018 crossref_primary_10_1136_jnnp_2022_329342 crossref_primary_10_1002_mds_27914 crossref_primary_10_1007_s11910_024_01349_8 crossref_primary_10_1136_jclinpath_2019_205952 crossref_primary_10_1007_s00702_017_1812_x crossref_primary_10_1016_j_jocn_2017_10_028 crossref_primary_10_1002_ana_25897 crossref_primary_10_1111_nan_12299 crossref_primary_10_3389_fnagi_2021_702639 crossref_primary_10_1097_01_NT_0000546409_20575_7c crossref_primary_10_1038_s41598_020_66497_6 crossref_primary_10_1111_neup_12189 crossref_primary_10_1002_mds_27392 crossref_primary_10_1007_s00455_024_10693_3 crossref_primary_10_1016_j_neuroscience_2019_05_029 crossref_primary_10_1136_bjophthalmol_2020_316499 crossref_primary_10_28982_josam_661757 crossref_primary_10_1007_s10072_024_07683_6 crossref_primary_10_1002_mdc3_13317 crossref_primary_10_1186_s40478_024_01907_8 crossref_primary_10_1111_fcp_12659 crossref_primary_10_1007_s00702_019_02097_7 crossref_primary_10_1016_j_nbd_2025_106872 crossref_primary_10_1136_bjo_2022_322762 crossref_primary_10_1038_s41598_020_77833_1 crossref_primary_10_1007_s10571_023_01419_4 crossref_primary_10_3233_ADR_230176 crossref_primary_10_1002_mds_26605 crossref_primary_10_1093_brain_aww175 crossref_primary_10_3389_fnins_2023_1146979 crossref_primary_10_1007_s00702_018_1872_6 crossref_primary_10_1038_s41582_022_00618_9 crossref_primary_10_1016_j_parkreldis_2015_09_015 crossref_primary_10_1016_j_wneu_2023_06_048 crossref_primary_10_1186_s13024_025_00819_y crossref_primary_10_1002_ana_25696 crossref_primary_10_1016_j_pathol_2024_10_006 crossref_primary_10_1002_mds_26360 crossref_primary_10_3389_fmed_2022_957700 crossref_primary_10_1177_09727531241259841 crossref_primary_10_3389_fneur_2017_00162 crossref_primary_10_1007_s00417_019_04239_9 crossref_primary_10_1016_j_pneurobio_2019_01_002 crossref_primary_10_1016_j_jagp_2017_01_005 crossref_primary_10_1111_nan_12249 crossref_primary_10_3389_fneur_2017_00710 crossref_primary_10_1016_j_tins_2020_05_001 crossref_primary_10_1080_08164622_2021_1984179 crossref_primary_10_1007_s00415_019_09430_w crossref_primary_10_1007_s00415_020_10094_0 crossref_primary_10_1111_neup_12691 crossref_primary_10_3390_ijms17020189 crossref_primary_10_1007_s00401_024_02769_z crossref_primary_10_1016_j_preteyeres_2020_100938 crossref_primary_10_3390_ijms24054391 crossref_primary_10_3390_brainsci13081173 crossref_primary_10_1136_jnnp_2023_331083 crossref_primary_10_3389_fneur_2019_00360 |
Cites_doi | 10.1097/ICU.0000000000000000 10.1097/NEN.0b013e31820376cc 10.1007/s00401-010-0664-3 10.1016/S0165-3806(01)00103-1 10.1016/S0197-4580(97)00057-2 10.1002/ana.10730 10.1159/000332802 10.1097/NEN.0b013e3182805c72 10.1002/mds.23891 10.1212/01.wnl.0000187889.17253.b1 10.1002/mds.25741 10.1212/WNL.44.11.2015 10.1038/ncb748 10.1111/bpa.12070 10.1007/BF02252618 10.1001/archneur.56.1.33 10.1212/WNL.80.7_supplement.P04.143 10.1080/02713680600776119 10.1111/j.1750-3639.2007.00054.x 10.1007/s10561-008-9067-2 10.1002/cne.903180204 10.1016/j.expneurol.2007.11.019 10.1002/cne.903320403 10.1007/s00401-009-0538-8 10.1111/j.1600-0404.1997.tb00286.x 10.1016/j.expneurol.2012.11.020 10.1523/JNEUROSCI.4132-11.2011 10.1007/s00401-008-0409-8 10.3233/JAD-121975 10.1002/cne.20761 10.1016/j.nbd.2011.06.009 |
ContentType | Journal Article |
Contributor | Caviness, John Belden, Christine Davis, Kathryn Jacobson, Sandra Driver-Dunckley, Erika |
Contributor_xml | – sequence: 1 givenname: John surname: Caviness fullname: Caviness, John – sequence: 2 givenname: Erika surname: Driver-Dunckley fullname: Driver-Dunckley, Erika – sequence: 3 givenname: Sandra surname: Jacobson fullname: Jacobson, Sandra – sequence: 4 givenname: Christine surname: Belden fullname: Belden, Christine – sequence: 5 givenname: Kathryn surname: Davis fullname: Davis, Kathryn |
Copyright | 2014 Elsevier Ireland Ltd Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier Ireland Ltd – notice: Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
CorporateAuthor | the Arizona Parkinson's Disease Consortium Arizona Parkinson's Disease Consortium |
CorporateAuthor_xml | – name: the Arizona Parkinson's Disease Consortium – name: Arizona Parkinson's Disease Consortium |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7TK 5PM |
DOI | 10.1016/j.neulet.2014.04.027 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | Neurosciences Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1872-7972 |
EndPage | 38 |
ExternalDocumentID | PMC4591751 24785101 10_1016_j_neulet_2014_04_027 S0304394014003309 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: U24 NS072026 – fundername: NIA NIH HHS grantid: P30 AG019610 – fundername: NIA NIH HHS grantid: P30 AG19610 |
GroupedDBID | --- --K --M -~X .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXLA AAXUO ABCQJ ABFNM ABFRF ABJNI ABLJU ABMAC ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSN SSZ T5K WH7 YCJ ~G- .55 .GJ 29N AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADIYS ADMUD ADNMO AEIPS AETEA AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION FEDTE FGOYB G-2 HMQ HVGLF HZ~ MVM R2- SEW SNS SSH WUQ X7M ZGI ZXP ZY4 CGR CUY CVF ECM EFKBS EIF NPM 7X8 7TK 5PM |
ID | FETCH-LOGICAL-c450t-bc1de76020e7e07501c2fe03dbbc042706506cacd97e870e62787976d1f005ff3 |
IEDL.DBID | .~1 |
ISSN | 0304-3940 1872-7972 |
IngestDate | Thu Aug 21 18:01:01 EDT 2025 Fri Jul 11 00:43:10 EDT 2025 Fri Jul 11 15:02:43 EDT 2025 Mon Jul 21 05:53:21 EDT 2025 Tue Jul 01 04:07:13 EDT 2025 Thu Apr 24 23:16:10 EDT 2025 Fri Feb 23 02:24:17 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Pathology Diagnosis Autopsy Melanopsin Lewy body Ganglion cell |
Language | English |
License | Copyright © 2014 Elsevier Ireland Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c450t-bc1de76020e7e07501c2fe03dbbc042706506cacd97e870e62787976d1f005ff3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 24785101 |
PQID | 1539469705 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4591751 proquest_miscellaneous_1543997868 proquest_miscellaneous_1539469705 pubmed_primary_24785101 crossref_citationtrail_10_1016_j_neulet_2014_04_027 crossref_primary_10_1016_j_neulet_2014_04_027 elsevier_sciencedirect_doi_10_1016_j_neulet_2014_04_027 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-06-13 |
PublicationDateYYYYMMDD | 2014-06-13 |
PublicationDate_xml | – month: 06 year: 2014 text: 2014-06-13 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Neuroscience letters |
PublicationTitleAlternate | Neurosci Lett |
PublicationYear | 2014 |
Publisher | Elsevier Ireland Ltd |
Publisher_xml | – name: Elsevier Ireland Ltd |
References | Beach, White, Hamilton, Duda, Iwatsubo, Dickson, Roncaroli, Buttini, Hladik, Sue, Noorigian, Adler (bib0115) 2008; 116 Buttner, Kuhn, Klotz, Steinberg, Voss, Bulgaru, Przuntek (bib0015) 1993; 6 Martinez-Navarrete, Martin-Nieto, Esteve-Rudd, Angulo, Cuenca (bib0050) 2007; 13 Fujiwara, Hasegawa, Dohmae, Kawashima, Masliah, Goldberg, Shen, Takio, Iwatsubo (bib0125) 2002; 4 Braak, Braak (bib0150) 2000; 247 (bib0085) 1997; 18 Ullmann, Moore, Temple, Fernandez-Juricic, Collin (bib0100) 2012; 79 Obi, Akiyama, Kondo, Shimomura, Hasegawa, Iwatsubo, Mizuno, Mochizuki (bib0110) 2008; 210 Simao (bib0030) 2013; 24 Maurage, Ruchoux, de, Surguchov, Destee (bib0060) 2003; 54 Simon, Martin-Martinelli, Savy, Verney, Raisman-Vozari, Nguyen-Legros (bib0145) 2001; 127 Leger, Fernagut, Canron, Leoni, Vital, Tison, Bezard, Vital (bib0055) 2011; 70 Beach, Adler, Lue, Sue, Bachalakuri, Henry-Watson, Sasse, Boyer, Shirohi, Brooks, Eschbacher, White, Akiyama, Caviness, Shill, Connor, Sabbagh, Walker (bib0035) 2009; 117 Beach, Adler, Dugger, Serrano, Hidalgo, Henry-Watson, Shill, Sue, Sabbagh, Akiyama (bib0135) 2013; 72 Kolb, Linberg, Fisher (bib0155) 1992; 318 Beach, Sue, Walker, Roher, Lue, Vedders, Connor, Sabbagh, Rogers (bib0070) 2008; 9 Lin, Adler, Hentz, Adler, Balcer, Galetta, Devick, Cronin, Arizona Parkinson's Disease Consortium (bib0005) 2013; 80 Ho, Troncoso, Knox, Stark, Eberhart (bib0065) 2014; 24 Hauw, Daniel, Dickson, Horoupian, Jellinger, Lantos, McKee, Tabaton, Litvan (bib0090) 1994; 44 Gastinger, Tian, Horvath, Marshak (bib0140) 2006; 31 Schmidt, Do, Dacey, Lucas, Hattar, Matynia (bib0160) 2011; 31 Muller, Kuhn, Buttner, Przuntek (bib0010) 1997; 96 Wassle, Grunert, Rohrenbeck (bib0105) 1993; 332 Beach, Adler, Sue, Vedders, Lue, White, Akiyama, Caviness, Shill, Sabbagh, Walker (bib0130) 2010; 119 Gelb, Oliver, Gilman (bib0075) 1999; 56 McKeith, Dickson, Lowe, Emre, O’Brien, Feldman, Cummings, Duda, Lippa, Perry, Aarsland, Arai, Ballard, Boeve, Burn, Costa, Del, Dubois, Galasko, Gauthier, Goetz, Gomez-Tortosa, Halliday, Hansen, Hardy, Iwatsubo, Kalaria, Kaufer, Kenny, Korczyn, Kosaka, Lee, Lees, Litvan, Londos, Lopez, Minoshima, Mizuno, Molina, Mukaetova-Ladinska, Pasquier, Perry, Schulz, Trojanowski, Yamada (bib0080) 2005; 65 Esteve-Rudd, Fernandez-Sanchez, Lax, de, Martin-Nieto, Cuenca (bib0045) 2011; 44 Archibald, Clarke, Mosimann, Burn (bib0020) 2011; 26 Cuenca, Herrero, Angulo, de, Martinez-Navarrete, Lopez, Barcia, Martin-Nieto (bib0040) 2005; 493 Walker, Lue, Adler, Shill, Caviness, Sabbagh, Akiyama, Serrano, Sue, Beach (bib0120) 2013; 240 Moreno-Ramos, Ito-Leon, Villarejo, Bermejo-Pareja (bib0165) 2013; 34 Bodis-Wollner, Miri, Glazman (bib0025) 2014; 29 Dickson, Rademakers, Hutton (bib0095) 2007; 17 Walker (10.1016/j.neulet.2014.04.027_bib0120) 2013; 240 Ullmann (10.1016/j.neulet.2014.04.027_bib0100) 2012; 79 Beach (10.1016/j.neulet.2014.04.027_bib0115) 2008; 116 Gastinger (10.1016/j.neulet.2014.04.027_bib0140) 2006; 31 Buttner (10.1016/j.neulet.2014.04.027_bib0015) 1993; 6 Dickson (10.1016/j.neulet.2014.04.027_bib0095) 2007; 17 Cuenca (10.1016/j.neulet.2014.04.027_bib0040) 2005; 493 Wassle (10.1016/j.neulet.2014.04.027_bib0105) 1993; 332 Fujiwara (10.1016/j.neulet.2014.04.027_bib0125) 2002; 4 Esteve-Rudd (10.1016/j.neulet.2014.04.027_bib0045) 2011; 44 Simon (10.1016/j.neulet.2014.04.027_bib0145) 2001; 127 Maurage (10.1016/j.neulet.2014.04.027_bib0060) 2003; 54 Beach (10.1016/j.neulet.2014.04.027_bib0070) 2008; 9 Schmidt (10.1016/j.neulet.2014.04.027_bib0160) 2011; 31 Archibald (10.1016/j.neulet.2014.04.027_bib0020) 2011; 26 Bodis-Wollner (10.1016/j.neulet.2014.04.027_bib0025) 2014; 29 Obi (10.1016/j.neulet.2014.04.027_bib0110) 2008; 210 Kolb (10.1016/j.neulet.2014.04.027_bib0155) 1992; 318 (10.1016/j.neulet.2014.04.027_bib0085) 1997; 18 Beach (10.1016/j.neulet.2014.04.027_bib0135) 2013; 72 Beach (10.1016/j.neulet.2014.04.027_bib0035) 2009; 117 Beach (10.1016/j.neulet.2014.04.027_bib0130) 2010; 119 Hauw (10.1016/j.neulet.2014.04.027_bib0090) 1994; 44 Muller (10.1016/j.neulet.2014.04.027_bib0010) 1997; 96 Braak (10.1016/j.neulet.2014.04.027_bib0150) 2000; 247 Leger (10.1016/j.neulet.2014.04.027_bib0055) 2011; 70 Gelb (10.1016/j.neulet.2014.04.027_bib0075) 1999; 56 Moreno-Ramos (10.1016/j.neulet.2014.04.027_bib0165) 2013; 34 Ho (10.1016/j.neulet.2014.04.027_bib0065) 2014; 24 McKeith (10.1016/j.neulet.2014.04.027_bib0080) 2005; 65 Martinez-Navarrete (10.1016/j.neulet.2014.04.027_bib0050) 2007; 13 Simao (10.1016/j.neulet.2014.04.027_bib0030) 2013; 24 Lin (10.1016/j.neulet.2014.04.027_bib0005) 2013; 80 17653035 - Mol Vis. 2007;13:949-61 23714377 - Brain Pathol. 2014 Jan;24(1):25-32 22142853 - Brain Behav Evol. 2012;79(1):26-44 23334596 - J Neuropathol Exp Neurol. 2013 Feb;72(2):130-6 24339212 - Mov Disord. 2014 Jan;29(1):15-22 18347928 - Cell Tissue Bank. 2008 Sep;9(3):229-45 18164295 - Exp Neurol. 2008 Apr;210(2):409-20 8216759 - J Neural Transm Park Dis Dement Sect. 1993;6(1):11-5 11813001 - Nat Cell Biol. 2002 Feb;4(2):160-4 9330978 - Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2 23201181 - Exp Neurol. 2013 Feb;240:190-204 16237129 - Neurology. 2005 Dec 27;65(12):1863-72 16877274 - Curr Eye Res. 2006 Jul-Aug;31(7-8):655-67 11287069 - Brain Res Dev Brain Res. 2001 Mar 29;127(1):87-93 17493041 - Brain Pathol. 2007 Jan;17(1):74-82 19399512 - Acta Neuropathol. 2009 Jun;117(6):613-34 9404998 - Acta Neurol Scand. 1997 Nov;96(5):293-6 8349840 - J Comp Neurol. 1993 Jun 22;332(4):407-20 18626651 - Acta Neuropathol. 2008 Sep;116(3):277-88 21157377 - J Neuropathol Exp Neurol. 2011 Jan;70(1):63-8 23271313 - J Alzheimers Dis. 2013;34(3):659-64 20306269 - Acta Neuropathol. 2010 Jun;119(6):689-702 1374766 - J Comp Neurol. 1992 Apr 8;318(2):147-87 16255027 - J Comp Neurol. 2005 Dec 12;493(2):261-73 22072661 - J Neurosci. 2011 Nov 9;31(45):16094-101 7969952 - Neurology. 1994 Nov;44(11):2015-9 10991663 - J Neurol. 2000 Apr;247 Suppl 2:II3-10 14520672 - Ann Neurol. 2003 Oct;54(4):542-7 24100368 - Curr Opin Ophthalmol. 2013 Nov;24(6):521-7 21953737 - Mov Disord. 2011 Nov;26(13):2387-95 9923759 - Arch Neurol. 1999 Jan;56(1):33-9 21742033 - Neurobiol Dis. 2011 Oct;44(1):102-15 |
References_xml | – volume: 332 start-page: 407 year: 1993 end-page: 420 ident: bib0105 article-title: Immunocytochemical staining of AII-amacrine cells in the rat retina with antibodies against parvalbumin publication-title: J. Comp. Neurol. – volume: 240 start-page: 190 year: 2013 end-page: 204 ident: bib0120 article-title: Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains publication-title: Exp. Neurol. – volume: 70 start-page: 63 year: 2011 end-page: 68 ident: bib0055 article-title: Protein aggregation in the aging retina publication-title: J. Neuropathol. Exp. Neurol. – volume: 31 start-page: 16094 year: 2011 end-page: 16101 ident: bib0160 article-title: Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function publication-title: J. Neurosci. – volume: 31 start-page: 655 year: 2006 end-page: 667 ident: bib0140 article-title: Retinopetal axons in mammals: emphasis on histamine and serotonin publication-title: Curr. Eye Res. – volume: 56 start-page: 33 year: 1999 end-page: 39 ident: bib0075 article-title: Diagnostic criteria for Parkinson disease publication-title: Arch. Neurol. – volume: 6 start-page: 11 year: 1993 end-page: 15 ident: bib0015 article-title: Disturbance of colour perception in Parkinson's disease publication-title: J. Neural Transm. Park. Dis. Dement. Sect. – volume: 119 start-page: 689 year: 2010 end-page: 702 ident: bib0130 article-title: Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders publication-title: Acta Neuropathol. – volume: 24 start-page: 521 year: 2013 end-page: 527 ident: bib0030 article-title: The contribution of optical coherence tomography in neurodegenerative diseases publication-title: Curr. Opin. Ophthalmol. – volume: 13 start-page: 949 year: 2007 end-page: 961 ident: bib0050 article-title: Alpha synuclein gene expression profile in the retina of vertebrates publication-title: Mol. Vis. – volume: 493 start-page: 261 year: 2005 end-page: 273 ident: bib0040 article-title: Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease publication-title: J. Comp. Neurol. – volume: 24 start-page: 25 year: 2014 end-page: 32 ident: bib0065 article-title: Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients publication-title: Brain Pathol. – volume: 17 start-page: 74 year: 2007 end-page: 82 ident: bib0095 article-title: Progressive supranuclear palsy: pathology and genetics publication-title: Brain Pathol. – volume: 4 start-page: 160 year: 2002 end-page: 164 ident: bib0125 article-title: Alpha-synuclein is phosphorylated in synucleinopathy lesions publication-title: Nat. Cell Biol. – volume: 80 year: 2013 ident: bib0005 article-title: Abnormal variable contrast acuity in Parkinson's disease publication-title: Neurology – volume: 44 start-page: 2015 year: 1994 end-page: 2019 ident: bib0090 article-title: Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy) publication-title: Neurology – volume: 116 start-page: 277 year: 2008 end-page: 288 ident: bib0115 article-title: Evaluation of alpha-synuclein immunohistochemical methods used by invited experts publication-title: Acta Neuropathol. – volume: 26 start-page: 2387 year: 2011 end-page: 2395 ident: bib0020 article-title: Visual symptoms in Parkinson's disease and Parkinson's disease dementia publication-title: Mov. Disord. – volume: 44 start-page: 102 year: 2011 end-page: 115 ident: bib0045 article-title: Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina publication-title: Neurobiol. Dis. – volume: 9 start-page: 229 year: 2008 end-page: 245 ident: bib0070 article-title: The Sun Health Research Institute Brain Donation Program: description and experience, 1987–2007 publication-title: Cell Tissue Bank – volume: 72 start-page: 130 year: 2013 end-page: 136 ident: bib0135 article-title: Submandibular gland biopsy for the diagnosis of Parkinson disease publication-title: J. Neuropathol. Exp. Neurol. – volume: 29 start-page: 15 year: 2014 end-page: 22 ident: bib0025 article-title: Venturing into the no-man's land of the retina in Parkinson's disease publication-title: Mov. Disord. – volume: 54 start-page: 542 year: 2003 end-page: 547 ident: bib0060 article-title: Retinal involvement in dementia with Lewy bodies: a clue to hallucinations? publication-title: Ann. Neurol. – volume: 318 start-page: 147 year: 1992 end-page: 187 ident: bib0155 article-title: Neurons of the human retina: a Golgi study publication-title: J. Comp. Neurol. – volume: 210 start-page: 409 year: 2008 end-page: 420 ident: bib0110 article-title: Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies publication-title: Exp. Neurol. – volume: 117 start-page: 613 year: 2009 end-page: 634 ident: bib0035 article-title: Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction publication-title: Acta Neuropathol. – volume: 65 start-page: 1863 year: 2005 end-page: 1872 ident: bib0080 article-title: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium publication-title: Neurology – volume: 247 start-page: II3 year: 2000 end-page: II10 ident: bib0150 article-title: Pathoanatomy of Parkinson's disease publication-title: J. Neurol. – volume: 127 start-page: 87 year: 2001 end-page: 93 ident: bib0145 article-title: Confirmation of the retinopetal/centrifugal nature of the tyrosine hydroxylase-immunoreactive fibers of the retina and optic nerve in the weaver mouse publication-title: Brain Res. Dev. Brain Res. – volume: 96 start-page: 293 year: 1997 end-page: 296 ident: bib0010 article-title: Distorted colour discrimination in Parkinson's disease is related to severity of the disease publication-title: Acta Neurol. Scand. – volume: 18 start-page: S1 year: 1997 end-page: S2 ident: bib0085 article-title: Consensus recommendations for the postmortem diagnosis of Alzheimer's disease publication-title: The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease – volume: 79 start-page: 26 year: 2012 end-page: 44 ident: bib0100 article-title: The retinal wholemount technique: a window to understanding the brain and behaviour publication-title: Brain Behav. Evol. – volume: 34 start-page: 659 year: 2013 end-page: 664 ident: bib0165 article-title: Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease publication-title: J. Alzheimers. Dis. – volume: 24 start-page: 521 year: 2013 ident: 10.1016/j.neulet.2014.04.027_bib0030 article-title: The contribution of optical coherence tomography in neurodegenerative diseases publication-title: Curr. Opin. Ophthalmol. doi: 10.1097/ICU.0000000000000000 – volume: 70 start-page: 63 year: 2011 ident: 10.1016/j.neulet.2014.04.027_bib0055 article-title: Protein aggregation in the aging retina publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1097/NEN.0b013e31820376cc – volume: 119 start-page: 689 year: 2010 ident: 10.1016/j.neulet.2014.04.027_bib0130 article-title: Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders publication-title: Acta Neuropathol. doi: 10.1007/s00401-010-0664-3 – volume: 13 start-page: 949 year: 2007 ident: 10.1016/j.neulet.2014.04.027_bib0050 article-title: Alpha synuclein gene expression profile in the retina of vertebrates publication-title: Mol. Vis. – volume: 127 start-page: 87 year: 2001 ident: 10.1016/j.neulet.2014.04.027_bib0145 article-title: Confirmation of the retinopetal/centrifugal nature of the tyrosine hydroxylase-immunoreactive fibers of the retina and optic nerve in the weaver mouse publication-title: Brain Res. Dev. Brain Res. doi: 10.1016/S0165-3806(01)00103-1 – volume: 18 start-page: S1 year: 1997 ident: 10.1016/j.neulet.2014.04.027_bib0085 article-title: Consensus recommendations for the postmortem diagnosis of Alzheimer's disease publication-title: Neurobiol. Aging doi: 10.1016/S0197-4580(97)00057-2 – volume: 54 start-page: 542 year: 2003 ident: 10.1016/j.neulet.2014.04.027_bib0060 article-title: Retinal involvement in dementia with Lewy bodies: a clue to hallucinations? publication-title: Ann. Neurol. doi: 10.1002/ana.10730 – volume: 79 start-page: 26 year: 2012 ident: 10.1016/j.neulet.2014.04.027_bib0100 article-title: The retinal wholemount technique: a window to understanding the brain and behaviour publication-title: Brain Behav. Evol. doi: 10.1159/000332802 – volume: 72 start-page: 130 year: 2013 ident: 10.1016/j.neulet.2014.04.027_bib0135 article-title: Submandibular gland biopsy for the diagnosis of Parkinson disease publication-title: J. Neuropathol. Exp. Neurol. doi: 10.1097/NEN.0b013e3182805c72 – volume: 247 start-page: II3 issue: Suppl 2 year: 2000 ident: 10.1016/j.neulet.2014.04.027_bib0150 article-title: Pathoanatomy of Parkinson's disease publication-title: J. Neurol. – volume: 26 start-page: 2387 year: 2011 ident: 10.1016/j.neulet.2014.04.027_bib0020 article-title: Visual symptoms in Parkinson's disease and Parkinson's disease dementia publication-title: Mov. Disord. doi: 10.1002/mds.23891 – volume: 65 start-page: 1863 year: 2005 ident: 10.1016/j.neulet.2014.04.027_bib0080 article-title: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium publication-title: Neurology doi: 10.1212/01.wnl.0000187889.17253.b1 – volume: 29 start-page: 15 year: 2014 ident: 10.1016/j.neulet.2014.04.027_bib0025 article-title: Venturing into the no-man's land of the retina in Parkinson's disease publication-title: Mov. Disord. doi: 10.1002/mds.25741 – volume: 44 start-page: 2015 year: 1994 ident: 10.1016/j.neulet.2014.04.027_bib0090 article-title: Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy) publication-title: Neurology doi: 10.1212/WNL.44.11.2015 – volume: 4 start-page: 160 year: 2002 ident: 10.1016/j.neulet.2014.04.027_bib0125 article-title: Alpha-synuclein is phosphorylated in synucleinopathy lesions publication-title: Nat. Cell Biol. doi: 10.1038/ncb748 – volume: 24 start-page: 25 year: 2014 ident: 10.1016/j.neulet.2014.04.027_bib0065 article-title: Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients publication-title: Brain Pathol. doi: 10.1111/bpa.12070 – volume: 6 start-page: 11 year: 1993 ident: 10.1016/j.neulet.2014.04.027_bib0015 article-title: Disturbance of colour perception in Parkinson's disease publication-title: J. Neural Transm. Park. Dis. Dement. Sect. doi: 10.1007/BF02252618 – volume: 56 start-page: 33 year: 1999 ident: 10.1016/j.neulet.2014.04.027_bib0075 article-title: Diagnostic criteria for Parkinson disease publication-title: Arch. Neurol. doi: 10.1001/archneur.56.1.33 – volume: 80 year: 2013 ident: 10.1016/j.neulet.2014.04.027_bib0005 article-title: Abnormal variable contrast acuity in Parkinson's disease publication-title: Neurology doi: 10.1212/WNL.80.7_supplement.P04.143 – volume: 31 start-page: 655 year: 2006 ident: 10.1016/j.neulet.2014.04.027_bib0140 article-title: Retinopetal axons in mammals: emphasis on histamine and serotonin publication-title: Curr. Eye Res. doi: 10.1080/02713680600776119 – volume: 17 start-page: 74 year: 2007 ident: 10.1016/j.neulet.2014.04.027_bib0095 article-title: Progressive supranuclear palsy: pathology and genetics publication-title: Brain Pathol. doi: 10.1111/j.1750-3639.2007.00054.x – volume: 9 start-page: 229 year: 2008 ident: 10.1016/j.neulet.2014.04.027_bib0070 article-title: The Sun Health Research Institute Brain Donation Program: description and experience, 1987–2007 publication-title: Cell Tissue Bank doi: 10.1007/s10561-008-9067-2 – volume: 318 start-page: 147 year: 1992 ident: 10.1016/j.neulet.2014.04.027_bib0155 article-title: Neurons of the human retina: a Golgi study publication-title: J. Comp. Neurol. doi: 10.1002/cne.903180204 – volume: 210 start-page: 409 year: 2008 ident: 10.1016/j.neulet.2014.04.027_bib0110 article-title: Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2007.11.019 – volume: 332 start-page: 407 year: 1993 ident: 10.1016/j.neulet.2014.04.027_bib0105 article-title: Immunocytochemical staining of AII-amacrine cells in the rat retina with antibodies against parvalbumin publication-title: J. Comp. Neurol. doi: 10.1002/cne.903320403 – volume: 117 start-page: 613 year: 2009 ident: 10.1016/j.neulet.2014.04.027_bib0035 article-title: Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction publication-title: Acta Neuropathol. doi: 10.1007/s00401-009-0538-8 – volume: 96 start-page: 293 year: 1997 ident: 10.1016/j.neulet.2014.04.027_bib0010 article-title: Distorted colour discrimination in Parkinson's disease is related to severity of the disease publication-title: Acta Neurol. Scand. doi: 10.1111/j.1600-0404.1997.tb00286.x – volume: 240 start-page: 190 year: 2013 ident: 10.1016/j.neulet.2014.04.027_bib0120 article-title: Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2012.11.020 – volume: 31 start-page: 16094 year: 2011 ident: 10.1016/j.neulet.2014.04.027_bib0160 article-title: Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4132-11.2011 – volume: 116 start-page: 277 year: 2008 ident: 10.1016/j.neulet.2014.04.027_bib0115 article-title: Evaluation of alpha-synuclein immunohistochemical methods used by invited experts publication-title: Acta Neuropathol. doi: 10.1007/s00401-008-0409-8 – volume: 34 start-page: 659 year: 2013 ident: 10.1016/j.neulet.2014.04.027_bib0165 article-title: Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease publication-title: J. Alzheimers. Dis. doi: 10.3233/JAD-121975 – volume: 493 start-page: 261 year: 2005 ident: 10.1016/j.neulet.2014.04.027_bib0040 article-title: Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease publication-title: J. Comp. Neurol. doi: 10.1002/cne.20761 – volume: 44 start-page: 102 year: 2011 ident: 10.1016/j.neulet.2014.04.027_bib0045 article-title: Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2011.06.009 – reference: 16255027 - J Comp Neurol. 2005 Dec 12;493(2):261-73 – reference: 17653035 - Mol Vis. 2007;13:949-61 – reference: 10991663 - J Neurol. 2000 Apr;247 Suppl 2:II3-10 – reference: 22142853 - Brain Behav Evol. 2012;79(1):26-44 – reference: 9923759 - Arch Neurol. 1999 Jan;56(1):33-9 – reference: 21953737 - Mov Disord. 2011 Nov;26(13):2387-95 – reference: 23334596 - J Neuropathol Exp Neurol. 2013 Feb;72(2):130-6 – reference: 23714377 - Brain Pathol. 2014 Jan;24(1):25-32 – reference: 23201181 - Exp Neurol. 2013 Feb;240:190-204 – reference: 23271313 - J Alzheimers Dis. 2013;34(3):659-64 – reference: 21157377 - J Neuropathol Exp Neurol. 2011 Jan;70(1):63-8 – reference: 16877274 - Curr Eye Res. 2006 Jul-Aug;31(7-8):655-67 – reference: 11287069 - Brain Res Dev Brain Res. 2001 Mar 29;127(1):87-93 – reference: 11813001 - Nat Cell Biol. 2002 Feb;4(2):160-4 – reference: 7969952 - Neurology. 1994 Nov;44(11):2015-9 – reference: 8349840 - J Comp Neurol. 1993 Jun 22;332(4):407-20 – reference: 14520672 - Ann Neurol. 2003 Oct;54(4):542-7 – reference: 18164295 - Exp Neurol. 2008 Apr;210(2):409-20 – reference: 9404998 - Acta Neurol Scand. 1997 Nov;96(5):293-6 – reference: 16237129 - Neurology. 2005 Dec 27;65(12):1863-72 – reference: 21742033 - Neurobiol Dis. 2011 Oct;44(1):102-15 – reference: 9330978 - Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2 – reference: 24339212 - Mov Disord. 2014 Jan;29(1):15-22 – reference: 17493041 - Brain Pathol. 2007 Jan;17(1):74-82 – reference: 24100368 - Curr Opin Ophthalmol. 2013 Nov;24(6):521-7 – reference: 20306269 - Acta Neuropathol. 2010 Jun;119(6):689-702 – reference: 22072661 - J Neurosci. 2011 Nov 9;31(45):16094-101 – reference: 8216759 - J Neural Transm Park Dis Dement Sect. 1993;6(1):11-5 – reference: 18347928 - Cell Tissue Bank. 2008 Sep;9(3):229-45 – reference: 1374766 - J Comp Neurol. 1992 Apr 8;318(2):147-87 – reference: 18626651 - Acta Neuropathol. 2008 Sep;116(3):277-88 – reference: 19399512 - Acta Neuropathol. 2009 Jun;117(6):613-34 |
SSID | ssj0005154 |
Score | 2.4611952 |
Snippet | •Structural and functional retinal changes are present in Parkinson's disease (PD).•Phosphorylated α-synuclein (psyn) is a specific biomarker of... Visual symptoms are relatively common in Parkinson's disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of... Visual symptoms are relatively common in Parkinson’s disease (PD) and optical coherence tomography has indicated possible retinal thinning. Accumulation of... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 34 |
SubjectTerms | Aged Aged, 80 and over alpha-Synuclein - metabolism Autopsy Case-Control Studies Diagnosis Female Ganglion cell Humans Lewy body Male Melanopsin Middle Aged Nerve Fibers - metabolism Parkinson Disease - metabolism Parkinson Disease - pathology Pathology Retinal Neurons - metabolism Retinal Neurons - ultrastructure |
Title | Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects |
URI | https://dx.doi.org/10.1016/j.neulet.2014.04.027 https://www.ncbi.nlm.nih.gov/pubmed/24785101 https://www.proquest.com/docview/1539469705 https://www.proquest.com/docview/1543997868 https://pubmed.ncbi.nlm.nih.gov/PMC4591751 |
Volume | 571 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1baxNBFB5KBfFFtPUSL2UE0acxe5nZ2X0MxRKVFkELfVvmSrbU2dBNHvLif_KP-Js8Z3Y3NCoWhDzkMptM5nLmO3u-8x1CXnsDGLQymnlbesaVskz5UrFce4AHRlQ6aumdnhXzc_7xQlzskeMxFwZplYPt7216tNbDO9NhNKfLppl-waAe1vUGFyEBrxyT-DiXuMrffb9B80hFLyGFEQBoPabPRY5XcGsYHSR48Sh4irVl_n48_Qk_f2dR3jiWTh6Q-wOepLO-yw_JngsH5HAWwJf-tqFvaGR4xlvnB-Tu6RBIPyT286Ltlov2enMFYNPSnz9YtwmobdwE1mDOSAtoMtpCinmO-BtR-hKfuJ5y3tEmUMyajglkbzs6BHtot9Z4d6d7RM5P3n89nrOh4AIzXCQrpk1qnSwAQTrpEEukJvMuya3WBmtyIJwrjDK2kg72uSsy2O6AZ2zqYaC9zx-T_dAG95RQYYpCq8R5mVhufKlNXilfZUYoDV-lJiQfx7k2gxo5FsW4qkfa2WXdz06Ns1Mn8MjkhLDtVctejeOW9nKcwnpnVdVwYNxy5atxxmvYcBhFUcG1666GI6LiRSUT8a826ObJsign5Em_Srb9zbgs0RBC33bWz7YBCn7vfhKaRRT-5gKca5E---9_9Zzcw1dIdUvzF2R_db12LwFUrfRR3DVH5M7sw6f52S-Imydg |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfGkIAXNDb-FDYwEoIn0_xznDxO06YC64TEJu3Nsh1bDRpOtbQPfeE78UX4TNw5SbUCYhJSH6raaRzbd_5d7nd3hLxxBjBoaTRzVeFYplTFlCsUS7UDeGB4qUMuvelZPrnIPl7yyy1yNMTCIK2y1_2dTg_auv9l3M_meF7X4y_o1MO63mAiRGCVl3fI3QzEF8sYvP9-g-cR8y6HFLoAoPsQPxdIXt4uYXqQ4ZWFjKdYXObv59Of-PN3GuWNc-lkhzzsASU97Mb8iGxZv0v2Dj0Y099W9C0NFM_w7nyX3Jv2nvQ9Un2eNe181lyvrgBtVvTnD9auPCY3rj2rMWikATgZlCHFQEe8R8h9iV9sxzlvae0phk2HCLJ3Le29PbRdany90z4mFyfH50cT1ldcYCbj0YJpE1dW5AAhrbAIJmKTOBulldYGi3IgnsuNMlUpLAi6zROQdwA0Vexgop1Ln5Bt33j7jFBu8lyryDoRVZlxhTZpqVyZGK40_JUakXSYZ2n6dORYFeNKDryzr7JbHYmrIyP4JGJE2PqqeZeO45b-YlhCubGtJJwYt1z5elhxCRKHbhTlbbNsJZwRZZaXIuL_6oN2nijyYkSedrtkPd4kEwVqQhjbxv5Zd8CM35stvp6FzN8ZB-uax8__-6lekfuT8-mpPP1w9ukFeYAtyHuL032yvbhe2gNAWAv9MkjQLwS4KO4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phosphorylated+%CE%B1-synuclein-immunoreactive+retinal+neuronal+elements+in+Parkinson%27s+disease+subjects&rft.jtitle=Neuroscience+letters&rft.au=Beach%2C+Thomas+G&rft.au=Carew%2C+Jeremiah&rft.au=Serrano%2C+Geidy&rft.au=Adler%2C+Charles+H&rft.date=2014-06-13&rft.eissn=1872-7972&rft.volume=571&rft.spage=34&rft_id=info:doi/10.1016%2Fj.neulet.2014.04.027&rft_id=info%3Apmid%2F24785101&rft.externalDocID=24785101 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-3940&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-3940&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-3940&client=summon |